Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, C-myc, Bcl-XL, NF-κB, and p53

被引:175
|
作者
Han, SS
Chung, ST
Robertson, DA
Ranjan, D
Bondada, S
机构
[1] Univ Kentucky, Dept Microbiol & Immunol, Lexington, KY 40536 USA
[2] Univ Kentucky, Sanders Brown Res Ctr Aging, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Gen Surg, Transplantat Sect, Lexington, KY 40536 USA
[4] Korea Food & Drug Adm, Div Immunotoxicol, Seoul 122020, South Korea
关键词
D O I
10.1006/clim.1999.4769
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been well known that curcumin is a powerful inhibitor of proliferation of several tumor cells. However, the molecular basis of the anti-proliferative effect of curcumin has not been investigated in detail. In this paper, we present evidence to show that curcumin inhibited proliferation of a variety of B lymphoma cells. At low concentrations curcumin inhibited the proliferation of BKS-2, an immature B cell lymphoma, more effectively than that of normal B lymphocytes and caused the apoptosis of BKS-2 cells in a dose- and time-dependent manner. Furthermore, curcumin downregulated the expression of survival genes egr-1, c-myc, and bcl-X-L as well as the tumor suppressor gene p53 in B cells. In addition, NF-kappa B binding activity was also downregulated almost completely by curcumin, Stimulation with CpG oligonucleotides or anti-CD40 overcame growth inhibition induced by low concentrations of curcumin, Our results suggest that curcumin caused the growth arrest and apoptosis of BKS-2 immature B cell lymphoma by downregulation of growth and survival promoting genes, (C) 1999 Academic Press.
引用
收藏
页码:152 / 161
页数:10
相关论文
共 50 条
  • [21] B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene
    D Lens
    LJA Coignet
    V Brito-Babapulle
    CSP Lima
    E Matutes
    MJS Dyer
    D Catovsky
    Leukemia, 1999, 13 : 873 - 876
  • [22] B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene
    Lens, D
    Coignet, LJA
    Brito-Babapulle, V
    Lima, CSP
    Matutes, E
    Dyer, MJS
    Catovsky, D
    LEUKEMIA, 1999, 13 (06) : 873 - 876
  • [23] Dentatin Induces Apoptosis in Prostate Cancer Cells via Bcl-2, Bcl-xL, Survivin Downregulation, Caspase-9,-3/7 Activation, and NF-κB Inhibition
    Arbab, Ismail Adam
    Looi, Chung Yeng
    Abdul, Ahmad Bustamam
    Cheah, Foo Kit
    Wong, Won Fen
    Sukari, Mohd Aspollah
    Abdullah, Rasedee
    Mohan, Syam
    Syam, Suvitha
    Arya, Aditya
    Taha, Manal Mohamed Elhassan
    Muharram, Bushra
    Mustafa, Mohd Rais
    Abdelwahab, Siddig Ibrahim
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [24] NF-κB-dependent Mechanism of Action of c-Myc Inhibitor 10058-F4: Highlighting a Promising Effect of c-Myc Inhibition in Leukemia Cells, Irrespective of p53 Status
    Sayyadi, Mohammad
    Safaroghli-Azar, Ava
    Safa, Majid
    Abolghasemi, Hassan
    Momeny, Majid
    Bashash, Davood
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (01): : 153 - 165
  • [25] Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression
    Yin, XY
    Grove, L
    Datta, NS
    Katula, K
    Long, MW
    Prochownik, EV
    CANCER RESEARCH, 2001, 61 (17) : 6487 - 6493
  • [26] Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-κB and Myc/Max
    Kirch, HC
    Flaswinkel, S
    Rumpf, H
    Brockmann, D
    Esche, H
    ONCOGENE, 1999, 18 (17) : 2728 - 2738
  • [27] Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-κB and Myc/Max
    Hans-Christoph Kirch
    Susanne Flaswinkel
    Heike Rumpf
    Dieter Brockmann
    Helmut Esche
    Oncogene, 1999, 18 : 2728 - 2738
  • [28] A Novel PTEN/Mutant p53/c-Myc/Bcl-XL Axis Mediates Context-Dependent Oncogenic Effects of PTEN with Implications for Cancer Prognosis and Therapy
    Huang, Xiaoping
    Zhang, Ying
    Tang, Yaqiong
    Butler, Napoleon
    Kim, Jungeun
    Guessous, Fadila
    Schiff, David
    Mandell, James
    Abounader, Roger
    NEOPLASIA, 2013, 15 (08): : 952 - +
  • [29] REARRANGEMENTS OF BCL-2, BCL-6, CYCLIN-D1, IGH, P53 AND C-MYC AS PROGNOSTIC MARKERS IN REPRESENTATIVE TURKISH DIFFUSE LARGE B- CELL LYMPHOMA PATIENTS
    Akay, O.
    Aras, B.
    Isiksoy, S.
    Toprak, C.
    Mutlu, F.
    Artan, S.
    Oner, U.
    Gulbas, Z.
    HAEMATOLOGICA, 2013, 98 : 649 - 649
  • [30] Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas
    Chang, CC
    Liu, YC
    Cleveland, RP
    Perkins, SL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (04) : 512 - 518